Population-Based Frequency of Ophthalmic Adverse Events in Melanoma, Other Cancers, and After Immune Checkpoint Inhibitor Treatment
David Braun, Darios Getahun, Vicki Y. Chiu, Anne L. Coleman, Gary N. Holland, Fei Yu, Lynn K. Gordon, Michel M. Sun
Topics & Concepts
MedicineMelanomaAdverse effectImmune systemPopulationOncologyImmunologyInternal medicineCancer researchEnvironmental healthOcular Oncology and TreatmentsCancer Immunotherapy and BiomarkersAutoimmune Neurological Disorders and Treatments